Image

Global Mesothelioma Treatment Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Mesothelioma Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Mesothelioma Treatment Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 240.00 USD Million
Diagram Market Size (Forecast Year) USD 478.22 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Mesothelioma Treatment Market, By Treatment Type (Chemotherapy, Targeted Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Mesothelioma Treatment Market

Mesothelioma Treatment Market Analysis and Size

The global mesothelioma treatment market is expected to witness significant growth during the forecast period. Multiple treatment landscape and increase in research collaboration between the companies and institution as well as granting special designation by the regulatory authority are considered as positive indicator for the growth of this market. In addition, advances in the treatment options and the presence of well-established healthcare facilities are some of the impacting factors for the growth of eosinophil driven diseases market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global mesothelioma treatment market in the forecast period 2022-2029. The expected CAGR of global mesothelioma treatment market is tend to be around 9.0% in the mentioned forecast period. The market was valued at USD 240 million in 2021, and it would grow upto USD 478.22 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Mesothelioma is a type of malignant cancer in which abnormal growth of cells originates from the tissues that lines the internal organs such as lungs, stomach, heart and other organs. It is majorly caused by exposure of asbestos fibres which get trapped in the lungs and abdomen, resulting in mesothelioma development. The patient usually experiences dyspnea, respiratory complication, and pleural effusion in mesothelioma.  

Mesothelioma Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment Type (Chemotherapy, Targeted Therapy, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Merck KGaA (Germany), Novartis AG (Switzerland), Beckman Coulter Inc. (U.S.), bioMerieux (France), Bio-Rad Laboratories, Inc (U.S.),  Danaher (U.S.), Hologic (U.S.), Gilead Sciences, Inc. (U.S.), Emcure Pharmaceuticals Limited. (India), Cipla Inc. (U.S.), Hetero (India), Bausch Health Companies Inc. (Canada), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), AstraZeneca (U.K.), Sanofi S.A. (France), Arena Pharmaceuticals, Inc. (U.S.), ONO PHARMACEUTICAL CO., LTD (Japan)

Market Opportunities

  • Increased Exposure To Increased Pollution
  • Increasing Demand for Retail Pharmacies

Global Mesothelioma Treatment Market Dynamics

Drivers

  • Increased Approval Gains for Efficient Combination Therapy

Most of the companies are focusing on gaining approvals for drugs that can treat this disease. There are very few companies that have patents for procedures, and there are some companies that are conducting clinical trials focusing on different combination drugs. For instance, Boehringer Ingelheim (B.I.) entered into phase 3 trial for its double-blind, randomized, phase 3 study of Nintedanib in combination with Pemetrexed  or Cisplatin followed by the continuation of Nintedanib monotherapy versus placebo in combination with Pemetrexed / Cisplatin followed by continuing placebo monotherapy for mesothelioma treatment.

  • High Prevalence of Mesothelioma

As per the reports of the Cancer Research U.K., 1 in every 710 women and 1 in every 140 men are diagnosed with malignant mesothelioma. It has been observed that there is a rising trend of malignant mesothelioma cases in men. This boosts the market growth.

Opportunities

  • Increased Exposure To Increased Pollution

People, especially mine workers are at a higher risk of developing mesothelioma due to asbestos (industrial pollutant). The chances of mesothelioma are increased in polluted areas by 2 to 10 fold compared to non-polluted areas. In addition, people exposed to a high dose of radiation, namely zeolites, are at risk of developing malignant mesothelioma.   

  • Increasing Demand for Retail Pharmacies

The rise in the number of drugs for mesothelioma delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Low Surveillance Rate

The 5-year mesothelioma survival rate for pleural mesothelioma is nearly 10%. Patients suffering from peritoneal mesothelioma have a 65% 5-year survival rate. According to the data from the May 2022 study, the annual number of malignant mesothelioma deaths amplified to 25%, from 489 in 1999 to 614 in 2020, and the yearly age-adjusted death rate for women reduced from 4.83 per 1 million in 1999 to 4.15 in 2020.

  • High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global mesothelioma treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global mesothelioma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In October 2020: FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma. The Food and Drug Administration (FDA) approved the combination of nivolumab plus ipilimumab for the better improvement of the patients.

Global Mesothelioma Treatment Market Scope

The global mesothelioma treatment market is segmented on the basis of treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

  • Chemotherapy
  • Targeted Therapy
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Mesothelioma Treatment Market Regional Analysis/Insights

The global mesothelioma treatment market is analysed and market size insights and trends are provided by treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global mesothelioma treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global mesothelioma treatment market throughout the forecasted period due to the government funding and awareness.

North America dominates the market due to the increase prevalence of mesothelioma and large availability of treatment options for patient suffering of mesothelioma.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Mesothelioma Treatment Market Share Analysis

The global mesothelioma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global mesothelioma treatment market.

Key players operating in the global mesothelioma treatment market include:

  • Merck KGaA (Germany)
  • Novartis AG (Switzerland)
  • Beckman Coulter Inc. (U.S.)
  • bioMerieux (France)
  • Bio-Rad Laboratories, Inc (U.S.)
  • Danaher (U.S.)
  • Hologic (U.S.)
  • Gilead Sciences, Inc. (U.S.)
  • Emcure Pharmaceuticals Limited. (India)
  • Cipla Inc. (U.S.)
  • Hetero (India)
  • Bausch Health Companies Inc. (Canada)
  • Johnson & Johnson Private Limited (U.S.)
  • Mylan N.V. (U.S.)
  • Sun Pharmaceutical Industries Limited (India)
  • AstraZeneca (U.K.)
  • Sanofi S.A. (France)
  • Arena Pharmaceuticals, Inc. (U.S.)
  • ONO PHARMACEUTICAL CO., LTD (Japan)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The global mesothelioma treatment market is projected USD 478.22 million by forecast.
The global mesothelioma treatment market is projected to grow at a CAGR of 9.0% during the forecast period of 2022-2029.
The major players operating in the Mesothelioma Treatment Market are Merck KGaA (Germany), Novartis AG (Switzerland), Beckman Coulter Inc. (U.S.), bioMerieux (France), Bio-Rad Laboratories, Inc (U.S.), Danaher (U.S.), Hologic (U.S.), Gilead Sciences, Inc. (U.S.), Emcure Pharmaceuticals Limited. (India), Cipla Inc. (U.S.), Hetero (India), Bausch Health Companies Inc. (Canada), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), AstraZeneca (U.K.), Sanofi S.A. (France), Arena Pharmaceuticals, Inc. (U.S.), ONO PHARMACEUTICAL CO., LTD (Japan).
The major countries covered in the Mesothelioma Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials